The loading of newly synthesised MHC class I molecules (MHCI) with peptides requires the involvement of several endoplasmic reticulum (ER)-resident cofactors including calnexin, calreticulin, transporter associated with antigen processing, ERp57 and tapasin. In the absence of tapasin, MHC I complexes are loaded with suboptimal peptides and their recognition by cytotoxic T cells raised to high-affinity, immunodominant peptide epitopes is impaired. Here, we describe the cloning and functional assessment of an alternative spliced form of tapasin. From the EST database, we obtained a partially spliced tapasin cDNA that retained introns 4-6. When transfected into the tapasin-deficient cell line 0.220, the cDNA produced an alternatively spliced tapasin transcript that contained intron 5 (74 bp). This introduced a new stop codon that terminated translation immediately before the putative transmembrane domain and led to a tapasin molecule containing the lumenal domain plus 8 extra novel amino acids at its C-terminus. This molecule promoted peptide loading of HLA-B5 in 0.220 cell line, and restored normal HLA-B5 surface expression. However, the peptides loaded onto HLA-B5 were suboptimal compared to those loaded onto HLA-B5 in the presence of wild-type tapasin.
Introduction
MHC class I complexes comprise a polymorphic, glycosylated, transmembrane heavy chain (HC), a noncovalently associated beta-2-microglobulin (b2-m) subunit and a short peptide, usually of 8-10 amino acids. 1 These complexes are expressed on the surface of virtually all nucleated cells and provide a means of discriminating self from nonself through recognition by cytotoxic T cells (CTLs) and natural killer (NK) cells. Most peptides that bind to MHC class I molecules are derived from a fraction of newly but aberrantly synthesised proteins that are targeted for cytosolic degradation. 2, 3 The peptides generated are transported by the peptide transporter associated with antigen processing (TAP) into the endoplasmic reticulum (ER), where they are loaded onto peptide-receptive MHC class I complexes. The peptide-loaded MHC class I complex is then located to the cell surface for subsequent recognition.
The assembly of MHC class I molecules with peptides that are able to stabilise the interaction between HC and b2-m is a critical event in antigen presentation and involves at least six ER-resident cofactors: calnexin, calreticulin, ERp57, TAP, tapasin and ERAAP. [4] [5] [6] [7] [8] [9] [10] The first five of these associate to form the peptide-loading complex (PLC), which is believed to promote the assembly of peptide-receptive complexes with peptide within the ER. Unlike calreticulin, calnexin and ERp57, which have general chaperone functions, tapasin has a specialised role in MHC class I assembly. 11 It mediates an interaction between TAP and newly synthesised MHC class I molecules through two functional sites; one binds to and stabilises the TAP heterodimer and the other associates to the peptide-receptive MHC class I complex. 12 The TAP protein is more stable when associated with tapasin, and peptide binding to TAP and translocation of peptides into the ER are increased when tapasin is present. Tapasin also plays an active role in the association of peptide-receptive MHC class I complexes with the other ER cofactors and is absolutely required for the association of MHC class I complexes with ERp57 and calreticulin within the PLC. 13 It also enhances the rate and extent of class I MHC loading with optimal peptides. [14] [15] [16] [17] In tapasin-deficient cells, the repertoire of class I-bound peptide is thus skewed towards less stably binding ones, a phenomenon that is consistent with the phenotype of C57BL/6 mice that lack tapasin and B2705 expressed in 0.220. [18] [19] [20] Tapasin is a type I transmembrane glycoprotein with a dilysine ER-retention motif (KxKxx) in its cytoplasmic tail. The tapasin gene consists of eight exons within a gene cluster approximately 190 kb centromeric to the HLA-DPB2 locus. The leader sequence and the prolinerich N-terminal portion of the lumenal domain are encoded by the first four exons. Exon 5 encodes the remainder of the lumenal domain, having homology to the immunoglobulin superfamily. Exon 6 encodes a putative transmembrane domain and exons 7 and 8 encode a short cytoplasmic domain that contains the ER-retention motif. 21 The TAP-binding site has been localised to exons 6-8. 12 Accordingly, an engineered construct of tapasin comprising its lumenal domains is secreted and has been shown to restore the antigenpresenting function of HLA-B8 in a tapasin-negative cell line in the absence of HLA-B8 association with TAP. 22 The N-terminal 50 amino acids of tapasin (encoded within exon 2) are essential for its interaction with class I MHC, CRT and Erp57, while a mutant mouse tapasin lacking amino acids 334-342 (encoded within exon 5) fails to bind to a mouse class I allele, but surprisingly, facilitates its assembly and expression. 23 We show here that an alternatively spliced form of the tapasin gene that encodes a truncated tapasin containing only the lumenal domains of tapasin plus eight novel C-terminal residues (KSWELCGI) is functional in terms of its ability to promote optimal peptide loading, restore class I surface expression and support a CTL response.
Results
An alternatively spliced tapasin gene (T5) encodes a soluble form of tapasin The published sequence of tapasin (GenBank, accession AF009510) was used to search the GenBank database of expressed tag sequences derived from a large panel of cDNA libraries, using the TBLASTN local alignment search tool. 24 Several cDNAs were identified as having a high degree of homology to tapasin and were acquired from the UK HGMP resource centre (www.hgmp.mrc. ac.uk) and sequenced. One of the clones revealed a 2202 bp sequence (Genbank, accession AF067286) that was identical to the published cDNA sequence over the first 1215 nucleotides, and thereafter was identical to the genomic sequence, having retained introns 4-7 (T5, Figure 1 ). A stop codon was identified within intron 4, resulting in a transcript that was predicted to encode a short version of tapasin including the proline-rich Nterminal region of the molecule, but lacking the Ig SF domain, transmembrane domain and cytoplasmic domain. To determine whether this truncated gene was functional, it was transfected it into the tapasin-defective B cell line 0.220-B5.
Surprisingly, RT-PCR analysis of the transfected cells with a primer pair spanning exons 4 and 6 gave a 200 bp product that was shorter than the expected product derived from the transfected gene (B500 bp), but longer than that expected for wild-type tapasin (Figure 2a ). This suggested that mRNA from the transfected cDNA was processed in such a way as to excise intron 4 but retain intron 5. We confirmed this using primers spanning intron 5 (Figure 2b) . A band of 194 bp was seen in 0.220-B5T5 (lane 5) corresponding to 78 bp of intron 5 plus 116 bp of flanking sequence. The latter 116 bp product was also seen in the nontransfected 0.220-B5 (lane 6), as 0.220 does possess genomic tapasin DNA but does not express a functional tapasin protein due to a point mutation in the splice-acceptor site of exon 2. 25 These data suggested that the constitutive mutant gene is otherwise processed normally-an observation that is consistent with the shortened tapasin seen in these cells. Interestingly, a minor RT-PCR product with retained intron 5 was also found in all control cell lines, suggesting that the alternatively spliced form may be generated in vivo from a naturally produced transcript. We assume that the low level of detectable 'wild-type' tapasin products in LBL721.220-B5T5 in Figure 2b is due to competition for transcription factors between the endogenous gene and the highly expressed transgene. Figure 2b also shows that both wild-type tapasin and a transcript including intron 5 are expressed in peripheral blood lymphocyte (PBL), the latter being the least abundant. The level of each RT-PCR product did not change after the activation of PBL with either 75 mg/ml conA, 10 mg ml PHA or 5 mg/ml PWM (data not shown).
To confirm the nature of the major tapasin transcript expressed in 0.220-B5T5, we cloned and sequenced the RT-PCR product from B5T5 using primers flanking exons 4 and 6 ( Figure 2a , lane 2). The sequencing results showed that intron 4 was indeed spliced out, while intron 5 was retained as part of the transcript (data not shown, Figure 2c ). As expected, 220-B5T5 cells expressed a tapasin protein that was slightly smaller (45 kDa) than wild-type tapasin (48 kDa) ( Figure 3a ). When T5 cDNA was translated in vitro, where no further processing of T5 transcripts can occur, the expected product of around 35 kDa was generated corresponding to exons 1-4 ( Figure 3a , lane 7). Western blot analysis of various cell lines was carried out in an attempt to identify either of these tapasin splice variants at the protein level. Figure 3b shows that human monocyte-derived dendritic cell lines of both immature and mature phenotype do not express any altered tapasin protein. Similarly, when a panel of tissue-specific protein blots were probed with the antitapasin antisera only the full-length form was seen in the spleen, lung and placenta, with little tapasin protein identified in uterus, brain and kidney lysates. Figure 3c shows the addition of the eight novel amino acids (KSWELCGI) that are in-frame with the terminal bases of the preceeding exon 5. The full-length tapasin would include a further 44 amino acids encoded from exons 6-8. Therefore, the 3 kDa difference between the two tapasin forms relates to the 36 amino-acid truncation of the full-length tapasin form. The truncated T5-derived tapasin is likely to be secreted, since an analogous soluble construct of tapasin comprising exons 1-5 with eight amino acids from exon 6 is secreted when transfected into 0.220 (data not shown).
Alternatively spliced tapasin restores class I surface expression and rescues the presentation of HIV-gag epitope in 0.220-B8 cell line to a B8-restricted CTL Many MHC class I alleles are expressed at low levels at the cell surface when transfected into the tapasindeficient cell LBL721.220 as a result of their inefficient assembly with peptides. 26, 27 Figure 4a shows that the cell surface expression of HLA-B5 is lower in 721.220 compared to that of class I in the tapasin-competent cell line 221.A24. However, surface HLA-B5 expression is restored by transfection of the T5 cDNA, to a level approaching MHC class I expression seen in 221-A24. A similar result was obtained for HLA-B8 (data not shown). This indicates that the alternatively spliced gene product is able to promote the loading of class I MHC with peptides.
The apparent restoration of HLA-B5 surface expression by tapasin T5 led us to determine whether the antigen-presenting function of class I molecules is restored by this protein. HLA-B8 is one of the class I MHC alleles whose surface expression is reduced by the absence of tapasin. As shown in Figure 4b , although 0.220-B8 is able to present exogenously added synthetic peptide to B8-restricted CTL, it is unable to present the HIV-1-gag epitope SLYNTVATL from an endogenous source (ie after vaccinia infection). However, presentation of the endogenous epitope was restored in 0.220-B8 transfected with T5. Alternatively spliced tapasin B Gao et al T5-encoded tapasin does not associate with TAP In order to confirm that the truncated tapasin did not associate with TAP due to the absence of a transmembrane and cytoplasmic domain, we looked for the coimmunprecipitation of the 45 kDa tapasin with TAP1. Figure 5a shows that full-length tapasin (48 kDa) is readily co-precipitated by an anti-TAP1 antibody in immunocompetent LBL 221.45 cells, while in the 220-B5T5 transfectant no coassociating tapasin is seen. The truncated protein could be detected in the cell lysate prior to immunoprecipitation (see Figure 3a , lane 5). The results indicate that alternatively spliced tapasin fails to associate with TAP, which confirms previous reports using deliberately engineered soluble tapasin constructs. Consequently, very little b2-m (a surrogate marker for class I MHC) was seen to coprecipitate with anti-TAP consistent with the MHC class I bridging function of tapasin (Figure 5b ).
T5-encoded tapasin promotes peptide loading and restores normal trafficking rate of B5 in 0.220 cells To investigate the effects of T5-encoded tapasin on the peptide loading and trafficking of HLA-B5, pulse chase experiments were carried out. Pulse-radiolabelled lysates were incubated overnight at 41C to permit dissociation of suboptimally loaded complexes prior to immunoprecipitation with the conformationally sensitive antibody W6/32. The majority of HLA-B5 synthesised in 0.220 were consistent with this phenotype leading to an insufficient number of W6/32 molecules for visualisation after immunoprecipitation (data not shown). However, when transfected with T5, there is a significant amount of HLA-B5 precipitated in the 0.220-B5 cells (Figure 6a) . The maturation rate of HLA-B5 is approximately the same as in 0.45, which expresses fulllength tapasin (Figure 6a) . Notably, the amount of endo-H-resistant HLA-B5 immunoprecipitated from 0.220-T5 begins to decline after 2 h chase, whereas in 0.45, the levels remain stable (Figure 6b) . We have previously shown that this phenomenon is indicative of suboptimal peptide loading of MHC class I, and suggests that a different repertoire of peptides may be loaded onto HLA-B5 in the presence of the soluble tapasin variant.
To test this possibility, we measured the thermostability of HLA-B5molecules assembled in 0.220-B5T5 compared to those synthesised in 0.45. We have shown that this assay is a good indicator of the average affinity of peptides bound to a cohort of class I MHC. 14, 28, 29 Lysates were precleared for 1 h at 41C with monoclonal antibody BB7.2 that was previously shown to remove all HLA-A2 molecules (present in 0.45 but not 0.220-B5T5, data not shown). Figure 7 shows that similar amounts of HLA-B5 were recovered from both cells at 41C, but those recovered from 0.220-B5T5 were less thermostable, with loss of almost half the molecules at 261C and over 60% loss at 371C. These results indicate that although the soluble tapasin restored cell surface expression of HLA-B5 and presentation of an immunodominant T-cell epitope, it did not completely restore the loading of optimal peptides capable of stabilising MHC class I at physiological temperatures.
Discussion
The presence of an incompletely processed tapasinencoding mRNA in several EST databases generated from libraries of diverse cellular and species origin suggested that the T5 transcript with retained introns 5-7 represented an alternatively spliced product and not a processing intermediate isolated from contaminating nuclear RNA. This was confirmed by our ability to detect transcripts that included intron 5 in highly purified preparations of cytosolic mRNA from various sources.
However, upon transfection into the B-cell line 0.220-B5, this transcript was processed further to remove intron 5, yielding a transcript that encoded the lumenal domain of tapasin. This is the first time that a soluble tapasin protein has been shown to arise from an mRNA containing all eight exons. Given these observations, it is possible that T5 represents a naturally occurring intermediate generated during the splicing of tapasin premRNA that is committed to the generation of a soluble isoform of the tapasin protein, but that this is a minor pathway given the low level of detection of 'intron 5-in.' transcripts in normal cells. Our inability to detect this soluble isoform does not imply that it does not naturally exist, as specific cellular signals may be necessary to induce its generation. Such signals may be pathogen derived or relate to specific cell processes, that is, crosspresentation/tolerance. It is possible that the rate Alternatively spliced tapasin B Gao et al at which intron 5 is excised from pre-mRNA relative to other introns (ie the sequence in which the introns are spliced) determines the level of T5-like transcripts, as has been shown for some metazoan genes. 30 Although we found that the levels of T5-like transcripts in normal lymphocytes did not change upon activation, other cellular changes may affect the alternative splicing of this gene, as has been described for others, including environmental stress, malignant transformation, developmental processes and infection. 31 We do not know whether the generation of a soluble tapasin will have any physiological significance. The expression of a soluble tapasin in normal cells may modulate the repertoire of peptides that are presented at the cell surface, which may in turn influence the recognition of target cells by CTLs and NK cells. Such codominant expression may be important for preventing the presentation of certain CTL epitopes, while at the same time maintaining good cell surface expression of tapasin-dependent class I MHC molecules that are ligands for NK-inhibitory receptors such as HLA-E. Alternatively, the production of soluble tapasin, which could access intracellular compartments distal to the ER, may be important in assisting peptide loading of MHC class I molecules at these alternative sites. This may have implications for MHC class I crosspresentation within compartments such as endosomes or the MIIC, where MHC class I complexes have been previously identified and investigated for peptide editing and exchange. [32] [33] [34] Materials and methods
Cells and antibodies
All cells were cultured in RPMI 1640 supplemented with 10% FCS, glutamine and antibiotics 721.220 (0.220), 721.221 (0.221) and their respective HLA transfectants, 0.220-B5, 0.220-B8, 0.221-A24 and HLA-B5-expressing hemizygous cell 721.45, were kind gifts from R DeMars (University of Wisconsin). Human DC cell lines were derived from CD14-positive monocytes as described previously. 35 PBLs were isolated from whole blood by standard percol centrifugation and maintained in culture overnight. The monoclonal antibody W6/32 was purified by standard protein A affinity chromatography. The antibody recognises a conformation-sensitive, monomorphic epitope on HLA-A, -B and -C, and requires that the HC be assembled with b2-m. 36 The antitapasin antibody (T66) was raised in rabbits against the first 62 amino acids of mature tapasin fused to GST protein using pGEX vector (Pharmacia). The anti-TAP2 antiserum was a gift from J Neefjes (Netherlands Cancer Institute). Rabbit anti-calreticulin antiserum was purchased from Affinity Bioreagents Inc. BBM1.1 was purified by standard protein A affinity chromatography and recognises human b2-m.
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Alternatively spliced tapasin gene subcloning cDNAs obtained from UK HGMP resource Centre (Cambridge, UK) based on their sequence homology to tapasin were sequenced both manually and automatically using an ABI sequencer. For transfections, the EST clone corresponding to exons 1-8 containing introns 5-7 (T5) was subcloned into pcDNA 3.0. Clones were sequenced to ensure correct orientation.
Transfection
A total of 1 Â 10 7 0.220-B5 cells were washed twice with 15 ml of phosphate-buffered saline (PBS), resuspended in 0.9 ml of PBS and then mixed with 100 ml of pcDNA3 containing the T5 fragment in 0.4 cm electrode gap curvettes (Bio-Rad) and kept on ice for 20 min. The electroporation was performed using the Gene Pulser (BioRad) set at 210 V and 960 mF. Stable transfectants were selected with 500 mg/ml G418 (Life Technology) and screened for MHC class I expression by FACS. The positive cell lines were subcloned by limited dilution and clones were selected for further analysis based on their cell surface expression of MHC class I.
Pulse chase and immunoprecipitation A total of 1 Â 10 7 cells were starved in 4 ml of cysteineand methionine-deficient RPMI 1640 (Sigma) with 10% dialysed FCS at 371C for 30 min. The cells were spun down and resuspended in 0.5 ml of the same solution containing 200 mCi Promix (Amersham) and incubated at 371C for a further 10 min. The labelled cells were washed with 20 ml of cold PBS and immediately lysed in 1 ml of TBS containing 1% digitonin, protease inhibitor cocktail (Sigma), and then kept on ice for 30 min. After removing nuclei by centrifugation at 13.00 r.p.m. for 30 min, the cell lysates were precleared by incubation at 41C either overnight (or for 20 min in the case of thermostability assays) with 1% normal rabbit serum (Sigma) and 50 ml of prewashed (0.1% digitonin) Staph A (Sigma). For immunoprecipitation of HLA-B5 with mAb W6/32, preclearing with mAb BB7.2 was performed. Antibodies were added to precleared supernatants for 90 min before adding 50 ml of Protein A-Sepharose 4B (Sigma) and rotated at 41C for further 30 min. Immunoprecipitates were resolved in 12.5% SDS-PAGE. Immunoglobulin bands were visualised with Coomassie blue to confirm equivalent loading of each lane. Gels were then soaked in amplify (Pharmacia) for 15 min, dried and exposed to an X-ray film overnight. Alternatively, gels were processed for immunoblotting (see below).
In vitro translation
Transcription and translation were carried out simultaneously using TNT Quick coupled Transcription/translation systems (Promega) according to the manufacturer's instructions. Briefly, 1 mg of plasmid was mixed with 40 ml of master mix and 20 mCi of Promix (Amersham) and nuclease-free water was added to a final volume of 50 ml. The reaction was carried out at 301C for 90 min.
Immunoblotting
Proteins were transferred from polyacrylamide gels to Hybond membrane (Amersham) electrophoretically over 90 min at 25 V. After blocking membranes with 2.5% skimmed milk in PBS, the membrane was incubated with anti-tapasin antiserum (1:10 000 dilution) in 2.5% skimmed milk/0.2% Tween-20 PBS for at least 1 h at room temperature. The membrane was washed with PBS/Tween-20 twice and incubated with anti-rabbit antibody conjugated to horseradish peroxidase. The membrane was thoroughly washed with PBST and visualised with an enhanced chemiluminescence detection system according to the manufacturer's instructions (Amersham). A multi-human tissue protein array (BioChain Institute, Hayward, CA, USA) was probed with tapasin antiserum (1:5000 dilution) and anti-rabbit antibody conjugated to horseradish peroxidase (as above).
RT-PCR mRNA was extracted from 1 Â 10 6 cells using an mRNA Direct kit (Dynal). cDNA was synthesised using standard random priming methods with MuMLV reverse transcriptase (Promega) and RNAse inhibitor (Promega). RT-PCR was carried out with the primers ATGGGG CACGCTATGCCTGT as the forward primer and CT ACGCTGTCCTCAAGGGAG as the reverse primer. Amplification was carried out as follows: 4 min at 941C, followed by 30 cycles of: 941C for 30 s, 451C for 30 s, 721C for 1 min and final extension for 8 min at 721C.
FACS analysis
In all, 2 Â 10 5 cells were incubated with a final concentration of 10 mg/ml W6/32 in RPMI 1640 with 10% FCS (10 mg/ml) at 41C for one hand washed with 10 ml cold PBS twice. The cells were stained for 45 min at 41C in 0.5 ml PBS containing a 200-fold dilution of goat antimouse Ig-FITC conjugate (Sigma). The cells were washed with 0.5 ml of cold PBS three times and suspended in 0.3 ml of PBS containing 0.7% formaldehyde. The samples were analysed in a Becton-Dickinson Flow Cytometer with minimum 20 000 cells counted.
CTL assays
Target cells were labelled with 51 Cr for 90 min after being infected with recombinant vaccinia virus at a multiplicity of five overnight at 371C. After washing, the cells were exposed to CTL in a standard 4-h Chromium release assay. For peptide-sensitised targets, 10 mM peptide was included in CTL assay.
